Miltenyi Biomedicine GmbH
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 2019-01-01
- Employees
- 51
- Market Cap
- -
MB-CART20.1 Melanoma
- First Posted Date
- 2019-03-27
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 9
- Registration Number
- NCT03893019
- Locations
- 🇩🇪
University Hospital of Cologne - Clinic for Internal Medicine I, Cologne, NRW, Germany
Safety of MB-CART2019.1 in Lymphoma Patients (MB-CART2019.1 Lymphoma / DALY 1)
- Conditions
- Interventions
- First Posted Date
- 2019-03-12
- Last Posted Date
- 2024-12-02
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 12
- Registration Number
- NCT03870945
- Locations
- 🇩🇪
Klinikum Augsburg, II. Med. Klinik Haematologie / Onkologie, Augsburg, Bavaria, Germany
🇩🇪University Hospital Cologne - Department for Internal Medicine I, Cologne, NRW, Germany
🇩🇪Universitätsklinikum Hamburg-Eppendorf, Department of Stem Cell Transplantation, Hamburg, Germany
MB-CART19.1 R/r CD19+ B-cell Malignancies (BCM)
- First Posted Date
- 2019-02-25
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 48
- Registration Number
- NCT03853616
- Locations
- 🇩🇪
Charite - Medical Clinic with focus on hematology, oncology and tumor immunology, Berlin, Germany
🇩🇪Charité - University clinic, pediatric clinic with focus on oncology and hematology, Berlin, Germany
🇩🇪University clinic, clinical for children and youth, Erlangen, Germany
MB-CART20.1 Lymphoma
- Conditions
- Interventions
- First Posted Date
- 2018-09-10
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 10
- Registration Number
- NCT03664635
- Locations
- 🇩🇪
Universitätsklikum Leipzig, AöR, Leipzig, Germany
🇩🇪University Hospital of Cologne - Clinic for Internal Medicine I, Cologne, Germany
Proof-of-Concept Trial on Selective Removal of SFlt-1 in Pregnant Women with Preeclampsia Via Apheresis
- Conditions
- Interventions
- First Posted Date
- 2016-10-04
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Miltenyi Biomedicine GmbH
- Target Recruit Count
- 21
- Registration Number
- NCT02923206
- Locations
- 🇩🇪
Universitätsklinikum Köln, Cologne, Germany
🇩🇪Universitätsklinikum Leipzig, Leipzig, Germany
🇬🇧Cambridge Clinical Trials Unit, Addenbrooke's Hospital, Cambridge, United Kingdom